Dogwood Therapeutics, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
DWTX on Nasdaq
Location
44 Milton Avenue, Alpharetta, GA

There are no Buy or Sell transactions made by insiders since 11/21/2023

Dogwood Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William Pridgen Director $992K Feb 26, 2024
Gregory Scott Duncan CHIEF EXECUTIVE OFFICER, Director $74.9K Feb 26, 2024
Toh Kean Meng Melvin Director Oct 7, 2024
John C. Thomas Director Feb 26, 2024
Richard Alan Burch Director Feb 26, 2024
Roger Michael Gendreau Chief Medical Officer Feb 26, 2024
Richard James Whitley Director Feb 26, 2024
Ralph Grosswald Svp Of Operations Feb 26, 2024
Angela Walsh Svp Of Finance Feb 26, 2024
Abel De La Rosa Director Feb 26, 2024
Yu Ying Choi Alan Abel Director Oct 7, 2024
David R. Keefer Director Feb 26, 2024
Sealbond Ltd 10%+ Owner Oct 7, 2024

Recent Insider Transactions by Companies or Individuals for Dogwood Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.